ClinConnect ClinConnect Logo
Search / Trial NCT06906302

RISE Versus Advocacy-based Enhanced Care as Usual for Patients Experiencing IPV

Launched by BOSTON UNIVERSITY · Apr 1, 2025

Trial Information

Current as of July 09, 2025

Not yet recruiting

Keywords

Rise Enhanced Care As Usual (Ecau) Healthcare Patients Self Efficacy Depression Post Traumatic Stress Disorders (Ptsd)

ClinConnect Summary

This clinical trial is studying how to improve treatment for veterans who have experienced intimate partner violence (IPV), which can lead to issues like depression and post-traumatic stress disorder (PTSD). The research will compare two different counseling methods: one that includes up to eight sessions covering topics like social support and health effects, and another that consists of a single session focused on education about IPV, safety, and available resources. The goal is to find out which approach helps patients feel more in control of their health and well-being.

To be eligible for this study, participants must be veterans receiving care at a specific clinic and have experienced physical, emotional, or sexual IPV in the past year. They should also be able to give permission for their sessions to be recorded. Those who have serious mental health conditions or thoughts of harming themselves or others will not be included. Participants will complete surveys about their health and feelings before starting the treatment, again after 12 weeks, and then every three months for a year. Overall, the study will last about 15 months and aims to provide better support for those affected by IPV.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • patients receiving care at an enrolled site/affiliated Community-Based Outpatient Clinic (CBOC)
  • report experience of past-year physical, psychological, and/or sexual IPV on an established screening tool used to detect IPV in VHA, and
  • be able to provide informed consent including permission to have intervention sessions recorded
  • Exclusion Criteria:
  • severe cognitive impairment,
  • suicide or homicide intent with a specific plan
  • untreated or unstable symptoms of mania or psychosis

About Boston University

Boston University, a leading research institution located in Boston, Massachusetts, is dedicated to advancing health sciences through innovative clinical trials and research initiatives. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive network of experts and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes and addressing pressing health challenges. Boston University is committed to ethical research practices, patient safety, and the dissemination of findings to foster greater understanding and advancements in medical care.

Locations

Boston, Massachusetts, United States

Minneapolis, Minnesota, United States

Philadelphia, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Katherine M Iverson, PhD

Principal Investigator

V Boston Healthcare System, BU CASchool Medicine Psychiatry

Melissa Dichter, PhD MSW

Principal Investigator

VA Philadelphia Healthcare System

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported